Apothio specializes in hemp research and commercialization, focusing on genetic development and regulatory advocacy.
Apothio has raised $348K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in March 2022.
Apothio is headquartered in Peru, United States.
Apothio specializes in hemp research and commercialization, focusing on genetic development and regulatory advocacy.
Apothio is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Apothio — Funding & Investors." VCBacked, March 1, 2022, https://www.vcbacked.co/company/apothio. Accessed October 25, 2026.
VCBacked. (2022). Apothio — Funding & Investors. Retrieved October 25, 2026, from https://www.vcbacked.co/company/apothio
{{cite web |title=Apothio — Funding & Investors |url=https://www.vcbacked.co/company/apothio |website=VCBacked |access-date=October 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated